Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

11.88
Delayed Data
As of Aug 18
 +0.12 / +1.02%
Today’s Change
8.18
Today|||52-Week Range
15.20
+20.24%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close11.76
Today’s open11.65
Day’s range11.61 - 11.93
Volume820,300
Average volume (3 months)1,037,372
Market cap$1.7B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-224.00%
Earnings growth (this year)-19.99%
Earnings growth (next 5 years)+12.98%
Revenue growth (last year)+8.61%
P/E ratioNM
Price/Sales8.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...-0.38-0.89%
RDUSRadius Health Inc+0.10+0.28%
XONIntrexon Corp-0.32-1.82%
XLRNAcceleron Pharma Inc-1.31-3.80%
Data as of 4:02pm ET, 08/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$146.7M
Annual profit (last year)-$103.0M
Net profit margin-70.23%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts